Insufficient scRNA-seq data for expression of DYRK3 at single-cell level.
Insufficient scRNA-seq data for expression of DYRK3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 538.86 | 459 / 459 | 95% | 8.65 | 1064 / 1118 |
ovary | 100% | 480.66 | 180 / 180 | 94% | 5.89 | 404 / 430 |
thymus | 100% | 451.85 | 652 / 653 | 94% | 5.15 | 569 / 605 |
uterus | 100% | 435.99 | 170 / 170 | 92% | 6.15 | 422 / 459 |
pancreas | 96% | 190.96 | 316 / 328 | 96% | 5.24 | 170 / 178 |
lung | 99% | 412.22 | 575 / 578 | 90% | 5.88 | 1043 / 1155 |
esophagus | 93% | 231.87 | 1351 / 1445 | 93% | 7.06 | 171 / 183 |
kidney | 100% | 271.67 | 89 / 89 | 84% | 5.94 | 759 / 901 |
skin | 87% | 396.02 | 1565 / 1809 | 92% | 7.66 | 434 / 472 |
adrenal gland | 98% | 204.81 | 254 / 258 | 68% | 2.78 | 157 / 230 |
stomach | 96% | 262.28 | 345 / 359 | 68% | 2.93 | 195 / 286 |
bladder | 100% | 240.67 | 21 / 21 | 60% | 2.74 | 301 / 504 |
prostate | 98% | 251.44 | 240 / 245 | 60% | 2.05 | 301 / 502 |
brain | 74% | 139.91 | 1967 / 2642 | 70% | 3.73 | 495 / 705 |
intestine | 89% | 205.38 | 863 / 966 | 50% | 2.08 | 265 / 527 |
liver | 93% | 182.08 | 210 / 226 | 46% | 2.16 | 188 / 406 |
adipose | 100% | 550.92 | 1202 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 336.32 | 1328 / 1335 | 0% | 0 | 0 / 0 |
heart | 99% | 889.75 | 855 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 93% | 6.68 | 42 / 45 |
spleen | 86% | 138.24 | 208 / 241 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 62% | 3.56 | 18 / 29 |
peripheral blood | 51% | 176.87 | 472 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 34% | 0.94 | 27 / 80 |
muscle | 23% | 30.77 | 186 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_1902751 | Biological process | positive regulation of cell cycle G2/M phase transition |
GO_0018105 | Biological process | peptidyl-serine phosphorylation |
GO_1903432 | Biological process | regulation of TORC1 signaling |
GO_0018107 | Biological process | peptidyl-threonine phosphorylation |
GO_0051301 | Biological process | cell division |
GO_0035063 | Biological process | nuclear speck organization |
GO_0030218 | Biological process | erythrocyte differentiation |
GO_0035617 | Biological process | stress granule disassembly |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_1903008 | Biological process | organelle disassembly |
GO_0080135 | Biological process | regulation of cellular response to stress |
GO_0006468 | Biological process | protein phosphorylation |
GO_0043518 | Biological process | negative regulation of DNA damage response, signal transduction by p53 class mediator |
GO_0005856 | Cellular component | cytoskeleton |
GO_0016607 | Cellular component | nuclear speck |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0000242 | Cellular component | pericentriolar material |
GO_0010494 | Cellular component | cytoplasmic stress granule |
GO_0005634 | Cellular component | nucleus |
GO_0004712 | Molecular function | protein serine/threonine/tyrosine kinase activity |
GO_0106310 | Molecular function | protein serine kinase activity |
GO_0004713 | Molecular function | protein tyrosine kinase activity |
GO_0004674 | Molecular function | protein serine/threonine kinase activity |
GO_0000287 | Molecular function | magnesium ion binding |
GO_0004672 | Molecular function | protein kinase activity |
GO_0005524 | Molecular function | ATP binding |
Gene name | DYRK3 |
Protein name | DYRK3 protein dual-specificity kinase (EC 2.7.12.1) Dual specificity tyrosine-phosphorylation-regulated kinase 3 (EC 2.7.12.1) (Regulatory erythroid kinase) (REDK) Dual specificity tyrosine phosphorylation regulated kinase 3 |
Synonyms | |
Description | FUNCTION: Dual-specificity protein kinase that promotes disassembly of several types of membraneless organelles during mitosis, such as stress granules, nuclear speckles and pericentriolar material . Dual-specificity tyrosine-regulated kinases (DYRKs) autophosphorylate a critical tyrosine residue in their activation loop and phosphorylate their substrate on serine and threonine residues . Acts as a central dissolvase of membraneless organelles during the G2-to-M transition, after the nuclear-envelope breakdown: acts by mediating phosphorylation of multiple serine and threonine residues in unstructured domains of proteins, such as SRRM1 and PCM1 . Does not mediate disassembly of all membraneless organelles: disassembly of P-body and nucleolus is not regulated by DYRK3 . Dissolution of membraneless organelles at the onset of mitosis is also required to release mitotic regulators, such as ZNF207, from liquid-unmixed organelles where they are sequestered and keep them dissolved during mitosis . Regulates mTORC1 by mediating the dissolution of stress granules: during stressful conditions, DYRK3 partitions from the cytosol to the stress granule, together with mTORC1 components, which prevents mTORC1 signaling . When stress signals are gone, the kinase activity of DYRK3 is required for the dissolution of stress granule and mTORC1 relocation to the cytosol: acts by mediating the phosphorylation of the mTORC1 inhibitor AKT1S1, allowing full reactivation of mTORC1 signaling . Also acts as a negative regulator of EPO-dependent erythropoiesis: may place an upper limit on red cell production during stress erythropoiesis . Inhibits cell death due to cytokine withdrawal in hematopoietic progenitor cells . Promotes cell survival upon genotoxic stress through phosphorylation of SIRT1: this in turn inhibits p53/TP53 activity and apoptosis . . |
Accessions | A0A3B3ISB2 O43781 ENST00000649163.1 ENST00000441486.5 ENST00000367106.1 [O43781-2] ENST00000367109.8 [O43781-1] ENST00000367108.7 [O43781-2] Q4G0U0 Q5SY34 |